Patent details

LUC00142 Product Name: Ravulizumab - Ultomiris®

Basic Information

Publication number:
LUC00142
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP141713727
Legal Status:
Inactive
Application number:
LUC00142
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1371
Marketing Authorization Type:
Marketing Authorization Date:
05/07/2019
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
20/12/2019
First Marketing Authorization date:
05/07/2019
Grant date:
06/07/2021
Activation date:
Publication date:
23/12/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
22/12/2033
SPC Extension Expiration:
22/12/2033
Rejection date:
Withdrawal date:

Owner

From:
08/03/2024
 
 

Name:
XENCOR, INC.
Address:
465 North Halstead Street, Suite 200, CA 91107, Pasadena, United States (US)

History of Owners

From:
20/12/2019
To:
08/03/2024

Name:
Xencor, Inc.
Address:
111 W. Lemon Avenue, Monrovia, CA 91016, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/12/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/01
Publication date:
13/01/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2021/09
Publication date:
03/08/2021
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
CO
Bulletin edition number:
2024/05
Publication date:
03/04/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20240000104A
Date Registered:
08/03/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
XENCOR, INC.
Address:
465 North Halstead Street, Suite 200, CA 91107, Pasadena, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/01/2029
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
16/09/2020 Outgoing Correspondence 1
20/12/2019 General Document 128
23/12/2019 Publication 1
06/07/2021 Outgoing Correspondence 1
23/12/2019 Outgoing Correspondence 1
06/07/2021 Certificate 1
20/12/2019 Application Form 4
06/07/2021 Publication 1
20/12/2019 Incoming Correspondence (Post) 3
16/03/2020 Incoming Correspondence (Post) 1
15/09/2020 Incoming Correspondence (Post) 1
20/12/2019 General Document 15
17/03/2020 Outgoing Correspondence 1
20/12/2019 General Document 37
16/09/2020 General Document 2
20/12/2019 General Document 16
20/12/2019 General Document 4
20/12/2019 General Document 143
08/03/2024 Request For Change 1
11/03/2024 Outgoing Correspondence 1